BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

859 related articles for article (PubMed ID: 28052038)

  • 1. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
    Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
    Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
    Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
    Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of laryngeal cancer prognostic biomarkers using an inflammatory gene-related, competitive endogenous RNA network.
    He Q; Tian L; Jiang H; Zhang J; Li Q; Sun Y; Zhao J; Li H; Liu M
    Oncotarget; 2017 Feb; 8(6):9525-9534. PubMed ID: 27902487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.
    Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X
    Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of an oesophageal cancer-specific ceRNA network based on miRNA, lncRNA, and mRNA expression data.
    Xue WH; Fan ZR; Li LF; Lu JL; Ma BJ; Kan QC; Zhao J
    World J Gastroenterol; 2018 Jan; 24(1):23-34. PubMed ID: 29358879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competing endogenous RNA networks and gastric cancer.
    Guo LL; Song CH; Wang P; Dai LP; Zhang JY; Wang KJ
    World J Gastroenterol; 2015 Nov; 21(41):11680-7. PubMed ID: 26556995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of competitive endogenous RNAs network in breast cancer.
    Wang X; Wan J; Xu Z; Jiang S; Ji L; Liu Y; Zhai S; Cui R
    Cancer Med; 2019 May; 8(5):2392-2403. PubMed ID: 30932362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering lncRNA mediated sponge interactions in breast cancer molecular subtypes.
    Olgun G; Sahin O; Tastan O
    BMC Genomics; 2018 Sep; 19(1):650. PubMed ID: 30180792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parameter optimization for constructing competing endogenous RNA regulatory network in glioblastoma multiforme and other cancers.
    Chiu YC; Hsiao TH; Chen Y; Chuang EY
    BMC Genomics; 2015; 16 Suppl 4(Suppl 4):S1. PubMed ID: 25917195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
    Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P
    PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of the whole coding and non-coding RNA transcriptome expression profiles and construction of the circRNA-lncRNA co-regulated ceRNA network in laryngeal squamous cell carcinoma.
    Zhao R; Li FQ; Tian LL; Shang DS; Guo Y; Zhang JR; Liu M
    Funct Integr Genomics; 2019 Jan; 19(1):109-121. PubMed ID: 30128795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of the aberrantly expressed lncRNA‑associated ceRNA network in breast cancer.
    Tuersong T; Li L; Abulaiti Z; Feng S
    Mol Med Rep; 2019 Jun; 19(6):4697-4710. PubMed ID: 31059025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of co-expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer.
    Yao Y; Zhang T; Qi L; Zhou C; Wei J; Feng F; Liu R; Sun C
    J Cell Mol Med; 2019 Dec; 23(12):8410-8419. PubMed ID: 31613058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a potential prognostic lncRNA-miRNA-mRNA signature in endometrial cancer based on the competing endogenous RNA network.
    Wang Y; Huang T; Sun X; Wang Y
    J Cell Biochem; 2019 Nov; 120(11):18845-18853. PubMed ID: 31338870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
    Xu Y; Chen J; Yang Z; Xu L
    Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
    Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
    Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma.
    Luo Q; Cui M; Deng Q; Liu J
    Mol Med Rep; 2019 Jun; 19(6):4685-4696. PubMed ID: 30957192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.
    Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X
    Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.